-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Reiterates Buy on Adicet Bio, Maintains $7 Price Target

Benzinga·03/21/2025 14:04:18
Listen to the news
Guggenheim analyst Yatin Suneja reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $7 price target.